Healthcare
More accessible medicines and fewer supply shortages: EU approves new rules
The Council of the EU has approved a new pharmaceutical package aimed at improving medicine access, ensuring supply security, and fostering innovation. The rules grant an eight-year data protection period for new drugs, include incentives for antibiotic development, and allow member states to mandate that pharmaceutical companies maintain sufficient stocks of essential medicines. The package now proceeds to the European Parliament for further review.
Why it matters
While this is a long-term EU policy, it aims to prevent medicine shortages and improve availability in Portugal over time, though no immediate change to your local pharmacy availability is expected.CNN PortugalRead original ↗
Useful?
